HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heiner Schäfer Selected Research

Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)

12/2020Recent insights into the role of L1CAM in cancer initiation and progression.
7/2014L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression.
1/2014The fatal alliance of cancer and T cells: How pancreatic tumor cells gather immunosuppressive T cells.
1/2014Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
10/2012EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation.
9/2012How two sites of inflammation promote carcinogenesis: The role of macrophages in inflammation associated carcinogenesis.
6/2012Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma.
1/2012Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent.
1/2011Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells.
10/2010Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heiner Schäfer Research Topics

Disease

29Neoplasms (Cancer)
10/2021 - 04/2003
14Adenocarcinoma
01/2021 - 02/2005
13Carcinogenesis
12/2019 - 09/2005
10Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 02/2002
5Inflammation (Inflammations)
12/2019 - 02/2010
4Neoplasm Metastasis (Metastasis)
12/2020 - 08/2010
4Colitis
11/2016 - 02/2010
3Colorectal Neoplasms (Colorectal Cancer)
12/2020 - 12/2005
3Chronic Pancreatitis
01/2015 - 05/2009
3Carcinoma (Carcinomatosis)
10/2012 - 08/2010
2Colonic Neoplasms (Colon Cancer)
12/2005 - 09/2005
1Obesity
05/2021
1Type 2 Diabetes Mellitus (MODY)
05/2021
1Starvation
03/2020
1Neoplasm Micrometastasis
01/2019
1Pancreatic Diseases (Pancreatic Disease)
01/2014
1Graft vs Host Disease (Graft-Versus-Host Disease)
04/2013
1Breast Neoplasms (Breast Cancer)
10/2012
1Virus Diseases (Viral Diseases)
06/2011
1Candidiasis (Moniliasis)
04/2011
1Asthma (Bronchial Asthma)
04/2011
1Crohn Disease (Crohn's Disease)
04/2011
1Atopic Dermatitis (Atopic Eczema)
04/2011
1Esophagitis
04/2011
1Lymphatic Metastasis
10/2010
1Endometrial Neoplasms (Endometrial Cancer)
08/2010
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2010
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2005
1Rheumatoid Arthritis
02/2005
1Autoimmune Diseases (Autoimmune Disease)
01/2005
1Pancreatic Ductal Carcinoma
02/2004

Drug/Important Bio-Agent (IBA)

13Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
12/2020 - 01/2009
7Pharmaceutical PreparationsIBA
12/2020 - 04/2003
7NF-kappa B (NF-kB)IBA
02/2010 - 02/2002
5Etoposide (VP 16)FDA LinkGeneric
11/2016 - 02/2002
5Transcription Factors (Transcription Factor)IBA
11/2016 - 02/2005
4GemcitabineFDA Link
05/2013 - 04/2003
2Insulin (Novolin)FDA Link
10/2021 - 01/2021
2NestinIBA
03/2020 - 01/2019
2Succinate Dehydrogenase (Fumarate Reductase)IBA
12/2019 - 01/2019
2Small Interfering RNA (siRNA)IBA
05/2017 - 04/2011
2Proteasome Endopeptidase Complex (Proteasome)IBA
11/2016 - 11/2011
2CarcinogensIBA
01/2015 - 01/2014
2Proteins (Proteins, Gene)FDA Link
01/2014 - 03/2007
2Dextrans (Dextran)FDA Link
01/2014 - 02/2010
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2014 - 02/2010
2LigandsIBA
05/2013 - 01/2009
2Transforming Growth Factors (Transforming Growth Factor)IBA
10/2012 - 05/2009
2CaspasesIBA
10/2008 - 03/2007
2Cholecystokinin B ReceptorIBA
12/2005 - 09/2005
2GastrinsIBA
12/2005 - 09/2005
2Interleukin-1beta (Interleukin 1 beta)IBA
02/2004 - 02/2002
1Hormones (Hormone)IBA
10/2021
1Insulin ReceptorIBA
10/2021
1Blood Glucose (Blood Sugar)IBA
05/2021
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1TNF-Related Apoptosis-Inducing LigandIBA
01/2021
1B7-H1 AntigenIBA
01/2021
1Tumor Suppressor Protein p53IBA
01/2021
1Cell Adhesion MoleculesIBA
12/2020
1Glucose (Dextrose)FDA LinkGeneric
03/2020
1Lactic Acid (Lactate)FDA LinkGeneric
03/2020
1ChemokinesIBA
09/2019
1Blocking AntibodiesIBA
05/2017
1Histone Deacetylase InhibitorsIBA
11/2016
1AntioxidantsIBA
11/2016
1Transforming Growth Factor beta (TGF-beta)IBA
02/2016
1Cadherins (E-Cadherin)IBA
01/2015
1VimentinIBA
01/2014
1Biomarkers (Surrogate Marker)IBA
01/2014
1Glutamine (L-Glutamine)FDA Link
04/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2012
1Paclitaxel (Taxol)FDA LinkGeneric
06/2012
1Caspase 8 (Caspase-8)IBA
06/2012
1AntibodiesIBA
06/2012
1Immunoglobulin G (IgG)IBA
06/2012
1Cytostatic AgentsIBA
06/2012
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2011
1CytokinesIBA
06/2011
1Acetylmuramyl-Alanyl-IsoglutamineIBA
04/2011
1DefensinsIBA
04/2011
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
04/2011
1IntegrinsIBA
08/2008
1Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA
12/2005
1Omeprazole (Prilosec)FDA LinkGeneric
09/2005
1Methionine (L-Methionine)FDA Link
02/2005
1Type II Tumor Necrosis Factor ReceptorsIBA
02/2005
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
02/2005
1Arginine (L-Arginine)FDA Link
02/2005
1Ligases (Synthetase)IBA
02/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2005
1InterleukinsIBA
02/2004
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2004
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2004

Therapy/Procedure

10Therapeutics
12/2020 - 02/2002
3Drug Therapy (Chemotherapy)
10/2008 - 04/2003
2Chemoprevention
01/2014 - 01/2014
1Aftercare (After-Treatment)
04/2004